• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
European Markets for Parkinson's Disease Therapeutics Product Image

European Markets for Parkinson's Disease Therapeutics

  • Published: May 2009
  • Region: Europe
  • 71 Pages
  • Frost & Sullivan

This research service discusses the market for Parkinson's disease. It analyses the various opportunities, recent developments, drug classes and gives a revenue forecasts.

1. Executive Summary
- Summary of Findings
-- Summary

2. Parkinson's Disease
-Disease Overview
- Scope
-- Overview
-- Prevalence and Incidence
-- Clinical Classification
-- Diagnosis
- Treatment Overview
-- Guidelines for Parkinson's Disease Management
-- Surgical and Related Options
-- Product and Pricing Analysis

3. Market for Parkinson's Disease Therapeutics
-Market Engineering Analysis
-- Market Overview
-- Market Engineering Measurements
- Market Dynamics
-- Challenges
-- Market Drivers
-- Market Restraints
- Market Forecasts and Trends
-- Disease Progression
-- Developments
-- Patient Forecasts
-- Revenue Forecasts

4. Dopamine Agonists Market
-Current Drugs
-- Dosage and Pricing Analysis
-- Product Analysis
- Market Dynamics
-- Market Drivers
-- Market Restraints

5. Levodopa/Carbidopa Market
-Current Drugs
-- Dosage and Pricing Analysis
-- Product Analysis
- Market Dynamics
-- Market Drivers
-- Market Restraints

6. Others
-Current Products and Pricing
-- COMT Inhibitors
-- MAO-B Inhibitors
-- Fixed Dose Combinations
- Market Dynamics
-- Market Drivers
-- Market Restraints
- Pipeline Analysis
-- Products in Phase III
-- Products in Phase II

7. Decision Support Databases
-List of Tables
-- Population Aged 65 Years and above
-- Female Population Aged 65 Years and above
-- Male Population Aged 65 Years and above
-- Number of Physicians
-- Hospital Discharge from Cerebrovascular Disease

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos